Insider Transactions in Q4 2022 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2022
|
Rishi Gupta Director |
SELL
Open market or private sale
|
Indirect |
2,170,368
-2.03%
|
$49,918,464
$23.2 P/Share
|
|
Dec 23
2022
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
2,170,368
-2.03%
|
$49,918,464
$23.2 P/Share
|
|
Dec 22
2022
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Indirect |
240,000
-23.66%
|
$480,000
$2.69 P/Share
|
|
Dec 22
2022
|
Rishi Gupta Director |
SELL
Open market or private sale
|
Indirect |
3,969,496
-5.01%
|
$83,359,416
$21.89 P/Share
|
|
Dec 22
2022
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
3,969,496
-5.01%
|
$83,359,416
$21.89 P/Share
|
|
Dec 20
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600,000
-3.44%
|
$1,200,000
$2.12 P/Share
|
|
Dec 20
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
600,000
-3.27%
|
$1,200,000
$2.12 P/Share
|
|
Nov 22
2022
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
170,000
+14.36%
|
-
|
|
Nov 22
2022
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
170,000
-7.72%
|
-
|
|
Nov 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,160
-0.08%
|
$13,160
$1.67 P/Share
|
|
Nov 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
454,856
-2.54%
|
$454,856
$1.6 P/Share
|
|
Nov 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,752
-0.92%
|
$28,752
$1.64 P/Share
|
|
Nov 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,264
-1.77%
|
$56,264
$1.6 P/Share
|
|
Nov 01
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
32,904
-0.18%
|
$32,904
$1.67 P/Share
|
|
Nov 01
2022
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
454,856
-2.41%
|
$454,856
$1.6 P/Share
|